Get the Stockscreener App
10.60
3.41%
0.35
After Hours:
10.61
0.010
+0.09%
Neuropace Inc Stock (NPCE) Forecast
The Neuropace Inc (NPCE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.1561, representing a -79.66% decrease from the current price of $10.60. The highest analyst price target is $3.4353, and the lowest is $0.8768.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NPCE Price Target
Average 1.9717
(-81.40% Downside)
Is Neuropace Inc (NPCE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.10 | Sell |
| STOCH(9,6) | 81.37 | Sell |
| STOCHRSI(14) | 77.82 | Neutral |
| MACD(12,26) | 0.9272 | Buy |
| ADX(14) | 28.58 | Buy |
| William %R | -4.1063 | Sell |
| CCI(14) | 70.45 | Neutral |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.671
Buy
|
9.7071
Buy
|
| MA20 |
8.624
Buy
|
8.9176
Buy
|
| MA50 |
7.3982
Buy
|
7.9573
Buy
|
| MA100 |
7.3981
Buy
|
7.8778
Buy
|
| MA200 |
9.3207
Buy
|
8.1078
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, NPCE could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on NPCE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.1 indicates that NPCE is overbought. This suggests that NPCE price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 81.37 indicates that NPCE is oversold. This means that NPCE price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.82 indicates that NPCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.58 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 70.45 indicates that NPCE is still overbought but not to an extreme extent.
Long-term NPCE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neuropace Inc financial reports and earnings history, Neuropace Inc (NPCE) stock could reach $3.0441 by 2030, $16.18 by 2040 and $47.27 by 2050. See the projected annual prices until 2050 of the Neuropace Inc stock below:
- Neuropace Inc (NPCE) is expected to reach an average price of $19.08 in 2035, with a high prediction of $19.00 and a low estimate of $18.81. This indicates an $79.96% rise from the last recorded price of $10.60.
- Neuropace Inc (NPCE) stock is projected to chart a bullish course in 2040, with an average price target of $18.93, representing an $78.58% surge from its current level. The forecast ranges from a conservative $9.5641 to a sky-high $16.18.
- Our analysts predict Neuropace Inc (NPCE) to jump 213.75% by 2045, soaring from $33.86 to an average price of $33.26, potentially reaching $33.26. While $33.86 is the low estimate, the potential upside is significant.
- Neuropace Inc (NPCE) stock is expected to climb by 2050, reaching an average of $47.69, a $349.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.27 and $47.99, respectively, highlighting the market's uncertainty.
Neuropace Inc Stock (NPCE) Year by Year Forecast
Neuropace Inc Stock (NPCE) Price Forecast for 2025
Neuropace Inc Stock (NPCE) is expected to reach an average price of $1.9717 in 2025, with a high prediction of $3.9337 and a low estimate of $0.00974. This indicates an -81.40% fall from the last recorded price of $10.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.1182 | $0.8768 | $3.4353 | -80.02% |
| February, 2025 | $2.2796 | $1.5167 | $3.2339 | -78.49% |
| March, 2025 | $0.061 | $0.00974 | $2.3324 | -99.42% |
| April, 2025 | $0.8948 | $0.1366 | $0.5652 | -91.56% |
| May, 2025 | $0.0934 | $0.8963 | $0.8363 | -99.12% |
| June, 2025 | $0.158 | $0.292 | $0.3651 | -98.51% |
| July, 2025 | $1.2278 | $0.8692 | $1.5107 | -88.42% |
| August, 2025 | $1.9564 | $1.575 | $1.8814 | -81.54% |
| September, 2025 | $2.655 | $2.6036 | $2.515 | -74.95% |
| October, 2025 | $3.9808 | $2.6822 | $3.6958 | -62.45% |
| November, 2025 | $3.8994 | $3.9849 | $3.8702 | -63.21% |
| December, 2025 | $2.4952 | $2.7309 | $3.9337 | -76.46% |
Neuropace Inc Stock (NPCE) Price Forecast for 2026
The predicted value for Neuropace Inc (NPCE) in 2026 is set at an average of $2.7035. Estimates vary from a peak of $4.7815 to a trough of $0.6255, indicating an -74.49% surge from the present price of $10.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2488 | $1.1066 | $1.1623 | -88.22% |
| February, 2026 | $1.2724 | $0.6352 | $0.6609 | -88.00% |
| March, 2026 | $0.681 | $1.171 | $1.2539 | -93.58% |
| April, 2026 | $0.3068 | $0.6968 | $0.2825 | -97.11% |
| May, 2026 | $0.7554 | $0.9083 | $0.6811 | -92.87% |
| June, 2026 | $0.674 | $1.1882 | $0.8097 | -93.64% |
| July, 2026 | $0.9998 | $0.9212 | $0.8248 | -90.57% |
| August, 2026 | $0.5484 | $0.8284 | $1.3988 | -94.83% |
| September, 2026 | $3.6859 | $0.6255 | $4.5002 | -65.23% |
| October, 2026 | $1.0872 | $1.0322 | $4.7815 | -89.74% |
| November, 2026 | $2.2986 | $0.9401 | $2.6286 | -78.31% |
| December, 2026 | $4.0929 | $1.6516 | $4.6664 | -61.39% |
Neuropace Inc Stock (NPCE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neuropace Inc (NPCE) is $7.1422, with a high forecast of $13.51 and a low forecast of $0.7746. This indicates an -32.62% decrease from the last price of $10.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.5543 | $2.6186 | $5.5643 | -47.60% |
| February, 2027 | $9.8656 | $4.7572 | $10.39 | -6.93% |
| March, 2027 | $12.38 | $8.7713 | $13.51 | +16.79% |
| April, 2027 | $8.5913 | $8.2384 | $12.74 | -18.95% |
| May, 2027 | $8.9626 | $7.5498 | $11.24 | -15.45% |
| June, 2027 | $7.39 | $7.05 | $10.14 | -30.28% |
| July, 2027 | $10.72 | $4.9867 | $11.00 | +1.16% |
| August, 2027 | $2.8955 | $2.7355 | $11.62 | -72.68% |
| September, 2027 | $2.244 | $1.834 | $4.8926 | -78.83% |
| October, 2027 | $0.8932 | $0.7746 | $4.9997 | -91.57% |
| November, 2027 | $2.7104 | $3.1875 | $2.4518 | -74.43% |
| December, 2027 | $3.232 | $2.8334 | $2.2947 | -69.51% |
Neuropace Inc Stock (NPCE) Price Forecast for 2028
In 2028, Neuropace Inc (NPCE) is projected to reach an average price of $6.7087, with a high projection of $9.2866 and a low estimate of $4.1309. This indicates an -36.71% fall from the last price of $10.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.3292 | $4.4506 | $3.7306 | -59.16% |
| February, 2028 | $4.6264 | $5.0135 | $4.3521 | -56.35% |
| March, 2028 | $3.6779 | $4.2579 | $3.6307 | -65.30% |
| April, 2028 | $4.0152 | $4.1309 | $3.6952 | -62.12% |
| May, 2028 | $5.6967 | $5.8267 | $5.7781 | -46.26% |
| June, 2028 | $6.4439 | $6.7353 | $6.3089 | -39.21% |
| July, 2028 | $5.9812 | $6.2312 | $6.7225 | -43.57% |
| August, 2028 | $6.7727 | $6.1141 | $6.0927 | -36.11% |
| September, 2028 | $7.3199 | $7.3199 | $7.2814 | -30.94% |
| October, 2028 | $8.2971 | $7.5542 | $7.5878 | -21.73% |
| November, 2028 | $8.9187 | $8.3244 | $8.3587 | -15.86% |
| December, 2028 | $9.5459 | $9.313 | $9.2866 | -9.94% |
Neuropace Inc Stock (NPCE) Price Forecast for 2029
The 2029 price forecast for Neuropace Inc Stock (NPCE) is $5.4136 on average, with a high prediction of $9.4474 and a low estimate of $1.3797. This represents an -48.93% decrease from the previous price of $10.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.5374 | $9.5553 | $9.4474 | -10.02% |
| February, 2029 | $6.8347 | $8.0747 | $9.3667 | -35.52% |
| March, 2029 | $6.0719 | $6.5433 | $6.2176 | -42.72% |
| April, 2029 | $7.0591 | $6.0205 | $5.8291 | -33.40% |
| May, 2029 | $5.7906 | $6.0806 | $6.5877 | -45.37% |
| June, 2029 | $6.2279 | $5.9536 | $5.5649 | -41.25% |
| July, 2029 | $6.2751 | $6.1266 | $5.9551 | -40.80% |
| August, 2029 | $6.0366 | $6.0623 | $5.9894 | -43.05% |
| September, 2029 | $6.0038 | $6.1109 | $5.9838 | -43.36% |
| October, 2029 | $0.6354 | $3.7253 | $5.8681 | -94.01% |
| November, 2029 | $2.0326 | $1.3797 | $1.0326 | -80.82% |
| December, 2029 | $2.9398 | $2.2712 | $2.8798 | -72.27% |
Neuropace Inc Stock (NPCE) Price Forecast for 2030
Neuropace Inc Stock (NPCE) is expected to reach an average price of $4.442 in 2030, with a high forecast of $8.8697 and a low forecast of $0.0143. This signifies an -58.09% decrease from the last price of $10.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0414 | $1.7614 | $3.0441 | -90.18% |
| February, 2030 | $1.1886 | $1.0643 | $0.7143 | -88.79% |
| March, 2030 | $1.4542 | $0.0143 | $1.7641 | -86.28% |
| April, 2030 | $5.237 | $1.3856 | $6.172 | -50.59% |
| May, 2030 | $6.9154 | $4.0927 | $8.8697 | -34.76% |
| June, 2030 | $4.7382 | $3.4782 | $7.6511 | -55.30% |
| July, 2030 | $4.3667 | $2.9996 | $6.70 | -58.80% |
| August, 2030 | $0.1915 | $0.47 | $5.2181 | -98.19% |
| September, 2030 | $0.9127 | $0.3756 | $5.1027 | -91.39% |
| October, 2030 | $2.6546 | $2.4888 | $2.9932 | -74.96% |
| November, 2030 | $1.8404 | $3.9161 | $3.4208 | -82.64% |
| December, 2030 | $9.0463 | $7.1619 | $6.8827 | -14.66% |
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):